This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Universite Bordeaux Segalen. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 4 Years Active: 2017
Title: The Innovations of Stephane Bonetto
Introduction
Stephane Bonetto is a notable inventor based in Antibes, France. He has made significant contributions to the field of molecular imaging, particularly in relation to atherosclerosis. His work focuses on developing antibodies that can specifically bind to atherosclerosis lesions, which is crucial for in vivo imaging.
Latest Patents
Stephane Bonetto holds a patent for "Antibodies for molecular imaging of vulnerable plaques in atherosclerosis." This patent describes antibodies that specifically bind to atherosclerosis lesions, enabling in vivo imaging and methods for visualizing these lesions in patients. He has 1 patent to his name, showcasing his innovative approach to medical imaging.
Career Highlights
Throughout his career, Bonetto has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Université Bordeaux Segalen. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
One of his notable collaborators is Kamel Deramchia. Their partnership has likely fostered innovative ideas and research in the field of molecular imaging.
Conclusion
Stephane Bonetto's work in developing antibodies for imaging atherosclerosis represents a significant advancement in medical technology. His contributions are vital for improving patient outcomes in cardiovascular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile